IN2012DN03819A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03819A
IN2012DN03819A IN3819DEN2012A IN2012DN03819A IN 2012DN03819 A IN2012DN03819 A IN 2012DN03819A IN 3819DEN2012 A IN3819DEN2012 A IN 3819DEN2012A IN 2012DN03819 A IN2012DN03819 A IN 2012DN03819A
Authority
IN
India
Prior art keywords
formula
tautomer
stereoisomer
stereoisomers
proportions
Prior art date
Application number
Other languages
English (en)
Inventor
Irene Erdelmeier
Sylvain Daunay
Original Assignee
Tetrahedron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetrahedron filed Critical Tetrahedron
Publication of IN2012DN03819A publication Critical patent/IN2012DN03819A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
IN3819DEN2012 2009-10-06 2010-10-06 IN2012DN03819A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0956968A FR2950890B1 (fr) 2009-10-06 2009-10-06 Procede de synthese de la 2-thiohistidine et analogues
PCT/EP2010/064947 WO2011042478A1 (fr) 2009-10-06 2010-10-06 Procede de synthese de la 2-thiohistidine et analogues

Publications (1)

Publication Number Publication Date
IN2012DN03819A true IN2012DN03819A (fr) 2015-08-28

Family

ID=41664356

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3819DEN2012 IN2012DN03819A (fr) 2009-10-06 2010-10-06

Country Status (14)

Country Link
US (1) US8835477B2 (fr)
EP (1) EP2486019B1 (fr)
JP (1) JP5731515B2 (fr)
KR (1) KR101773995B1 (fr)
CN (1) CN102596915B (fr)
AU (1) AU2010305397B2 (fr)
BR (1) BR112012007944A2 (fr)
CA (1) CA2776833C (fr)
ES (1) ES2540279T3 (fr)
FR (1) FR2950890B1 (fr)
HU (1) HUE025487T2 (fr)
IN (1) IN2012DN03819A (fr)
RU (1) RU2548153C2 (fr)
WO (1) WO2011042478A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3021655B1 (fr) 2014-05-30 2016-07-08 Tetrahedron Nouveaux composes de type 5-acylsulfanyl-histidine en tant que precurseurs des 5-sulfanylhistidines correspondantes et de leurs disulfures
JP6864131B1 (ja) * 2020-03-04 2021-04-28 長瀬産業株式会社 Ｌ−エルゴチオネイン含有組成物
EP4326302A1 (fr) * 2021-04-22 2024-02-28 University of Vermont and State Agricultural College Substitution de l'histidine par la 2-thiohistidine dans des peptides bioactifs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707087B1 (fr) * 1993-06-28 1995-10-13 Bioxytech Nouveau procédé de préparation de l'ergothionéine.
FR2714380B1 (fr) 1993-12-24 1996-05-24 Bioxytech Utilisation de dérivés 2-mercapto-imidazole substitués en position 4 (ou 5) comme agents antioxydants, leur procédé de préparation et leurs applications en pharmacie, cosmétique ou alimentaire.
WO1998003164A1 (fr) * 1996-07-22 1998-01-29 Monsanto Company Composes a base de sulfone de thiol servant d'inhibiteurs des metalloproteases
EP1363879A2 (fr) * 2000-10-11 2003-11-26 Esperion Therapeutics Inc. Composes et compositions de sulfure et de disulfure pour le traitement du cholesterol et utilisations associees
US7767826B2 (en) * 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
FR2950889B1 (fr) 2009-10-06 2011-11-18 Tetrahedron Procede de synthese de l'ergothioneine et analogues

Also Published As

Publication number Publication date
WO2011042478A1 (fr) 2011-04-14
FR2950890A1 (fr) 2011-04-08
EP2486019B1 (fr) 2015-03-25
RU2012117977A (ru) 2013-11-20
CN102596915A (zh) 2012-07-18
ES2540279T3 (es) 2015-07-09
JP2013506705A (ja) 2013-02-28
FR2950890B1 (fr) 2011-12-30
AU2010305397B2 (en) 2014-07-10
KR20120100977A (ko) 2012-09-12
RU2548153C2 (ru) 2015-04-20
US20120330029A1 (en) 2012-12-27
CA2776833A1 (fr) 2011-04-14
US8835477B2 (en) 2014-09-16
BR112012007944A2 (pt) 2015-09-22
AU2010305397A1 (en) 2012-05-24
CA2776833C (fr) 2019-03-19
KR101773995B1 (ko) 2017-09-01
EP2486019A1 (fr) 2012-08-15
JP5731515B2 (ja) 2015-06-10
CN102596915B (zh) 2016-04-20
HUE025487T2 (en) 2016-04-28

Similar Documents

Publication Publication Date Title
UA96961C2 (uk) Азаадамантанові похідні і способи застосування
UA97834C2 (ru) Производные сульфониламида для лечения анормального роста клеток
MX2009012847A (es) Analogos dipeptidicos como inhibidores de factores de coagulacion.
MX2009003834A (es) Derivados de pirrolidina como inhibidores de iap.
MY150596A (en) Hsp90 inhibitors
MX340573B (es) Proceso para la fabricacion de compuestos farmaceuticamente activos.
MX2009003739A (es) Derivados de hidrobenzamida como inhibidores de hsp90.
UA101835C2 (uk) Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти
MX2012000231A (es) Nuevos aza-biciclo-hexanos.
JO3067B1 (ar) بيرميدينات بيرازولو امينو كمثبطات ل fak
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
MX2011011776A (es) Nuevos profarmacos de triptolite.
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
WO2012172566A3 (fr) Nouveaux inhibiteurs sglt
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
UA103329C2 (ru) Соли соединений-ингибиторов вич
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
MX2012006524A (es) Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol.
MX2010009876A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente.
TW200740729A (en) Methods for preparing glutamic acid derivatives
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
IN2012DN03819A (fr)
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.
WO2012015687A3 (fr) Conjugués médicament-ligand, leur synthèse et leurs intermédiaires
MX2007008349A (es) Nueva sintesis de una etapa de aminas disustituidas utiles.